Janssen Research & Development, Llc
Clinical trials sponsored by Janssen Research & Development, Llc, explained in plain language.
-
Depression drug study halted: aticaprant safety trial ends early
Disease control TerminatedThis study looked at the long-term safety of a drug called aticaprant when taken together with standard antidepressants for people with major depressive disorder. About 871 adults were planned to join, but the study was stopped early. The main goal was to track side effects and s…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Depression drug trial halted: did it fail to boost joy?
Symptom relief TerminatedThis study tested whether adding aticaprant to standard antidepressants could improve symptoms in adults with major depression who also have severe loss of interest or pleasure (anhedonia). About 101 people were enrolled, but the trial was stopped early. The goal was to measure c…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC